Specialized interferon action in COVID-19

Matthew D. Galbraith(University of Colorado Anschutz Medical Campus), Joaquı́n M. Espinosa(University of Colorado Anschutz Medical Campus), Seth Russell(University of Colorado Denver), Julie A. Reisz(University of Colorado Anschutz Medical Campus), Fabia Gamboni(Ospedale Policlinico San Martino), Elena W.Y. Hsieh(Children's Hospital Colorado), Francesca Cendali(University of Colorado Anschutz Medical Campus), Kejun Guo(University of Colorado Anschutz Medical Campus), Ryan M. Baxter(University of Colorado Anschutz Medical Campus), Kelly D. Sullivan(University of Colorado Anschutz Medical Campus), Kimberly R. Jordan(University of Colorado Anschutz Medical Campus), Kohl T. Kinning(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Mario L. Santiago(University of Colorado Anschutz Medical Campus), Cara C. Wilson(University of Colorado Anschutz Medical Campus), Andrew A. Monte(Washington Poison Center), Jessica R. Shaw(University of Colorado Anschutz Medical Campus), Ross E. Granrath(University of Colorado Anschutz Medical Campus), Keith P. Smith(University of Colorado Anschutz Medical Campus), Tellen D. Bennett(Children's Hospital Colorado), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), Tusharkanti Ghosh(Colorado School of Public Health), Monika Dzieciątkowska(University of Colorado Anschutz Medical Campus), Paula Araya(University of Colorado Anschutz Medical Campus)
Proceedings of the National Academy of Sciences
February 25, 2022
Cited by 94


Related Papers